Fig 2:

Effects of PBM and/or CoQ₁₀ therapies on the A) MDA, B) GPx, C) SOD, D) TAC, and E) GSH levels in the PFC and HIP areas after the restraint stress paradigm. n = 6. Data represent mean ± S.E.M. ^**p < 0.01, ^***p < 0.001 vs. control group. ^#p < 0.05, ^##p < 0.01, ^###p < 0.001 vs. RS group. (CoQ₁₀, coenzyme Q₁₀; GPx, glutathione peroxidase; GSH, glutathione; HIP, hippocampus; MDA, malondialdehyde; PBM, photobiomodulation; PFC, prefrontal cortex; RS, restraint stress; SOD, superoxide dismutase; TAC, total antioxidant capacity).